BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND LDH
311 results:

  • 1. Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid.
    Guo X; Wan P; Shen W; Sun M; Peng Z; Liao Y; Huang Y; Liu R
    J Transl Med; 2024 Apr; 22(1):401. PubMed ID: 38689341
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Salivary Biomarkers for Oral cancer Detection: An Exploratory Systematic Review.
    Bastías D; Maturana A; Marín C; Martínez R; Niklander SE
    Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473882
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Evaluation of a novel model incorporating serological indicators into the conventional TNM staging system for nasopharyngeal carcinoma.
    Ding C; Dai DY; Luo ZK; Wang GY; Dong Z; Qin GJ; Du XJ; Ma J
    Oral Oncol; 2024 Apr; 151():106725. PubMed ID: 38430711
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Primary thyroid lymphoma: a case series.
    Sakhri S; Zemni I; Ayadi MA; Kamoun S; Chargui R; Ben Dhiab T
    J Med Case Rep; 2024 Feb; 18(1):108. PubMed ID: 38395921
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Clinical outcomes of cetuximab-based treatment for distant metastatic head and neck squamous cell carcinoma: A real-world study using Taiwan head neck Society registry database.
    Lu HJ; Hsieh MC; Wang HM; Hsieh JC; Yen CJ; Wu SY; Huang HC; Wang HC; Chu PY; Chen TH; Chien CY; Huang TL; Chang YF; Hua CH; Lien MY; Chen JP; Lu WC; Lin JC; Wang CC; Liu YC; Yang MH; Lou PJ
    Head Neck; 2024 May; 46(5):1063-1073. PubMed ID: 38385970
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Efficacy and safety of neoadjuvant sintilimab in combination with FLOT chemotherapy in patients with HER2-negative locally advanced gastric or gastroesophageal junction adenocarcinoma: an investigator-initiated, single-arm, open-label, phase II study.
    Li N; Li Z; Fu Q; Zhang B; Zhang J; Wan XB; Lu CM; Wang JB; Deng WY; Ma YJ; Bie LY; Wang MY; Li J; Xia QX; Wei C; Luo SX
    Int J Surg; 2024 Apr; 110(4):2071-2084. PubMed ID: 38320099
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Clinical management of NUT carcinoma (NC) in Germany: Analysis of survival, therapy response, tumor markers and tumor genome sequencing in 35 adult patients.
    Kloker LD; Sidiras M; Flaadt T; Brecht IB; Deinzer CKW; Groß T; Benzler K; Zender L; Lauer UM
    Lung Cancer; 2024 Mar; 189():107496. PubMed ID: 38301600
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Forward Genetic Screens Identify Mechanisms of Resistance to Small-Molecule Lactate Dehydrogenase Inhibitors.
    Frank AR; Vandiver F; McFadden DG
    ACS Chem Biol; 2024 Feb; 19(2):471-482. PubMed ID: 38270591
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A novel model for predicting prognosis and response to immunotherapy in nasopharyngeal carcinoma patients.
    Wu YX; Tian BY; Ou XY; Wu M; Huang Q; Han RK; He X; Chen SL
    Cancer Immunol Immunother; 2024 Jan; 73(1):14. PubMed ID: 38236288
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The radiation- and chemo-sensitizing capacity of diclofenac can be predicted by a decreased lactate metabolism and stress response.
    Schwab M; Dezfouli AB; Khosravi M; Alkotub B; Bauer L; Birgani MJT; Multhoff G
    Radiat Oncol; 2024 Jan; 19(1):7. PubMed ID: 38229111
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Concurrent chemoradiotherapy versus radiotherapy alone in older patients with stage II nasopharyngeal carcinoma after intensity-modulated radiotherapy: A propensity score-matched cohort study.
    Wang F; Zhou L; Zhang LJ; Xie CB; Liao ZW; Lin XD; Wen YF
    Radiother Oncol; 2024 Feb; 191():110081. PubMed ID: 38185256
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Analysis of multiple programmed cell death-related prognostic genes and functional validations of necroptosis-associated genes in oesophageal squamous cell carcinoma.
    Cao K; Zhu J; Lu M; Zhang J; Yang Y; Ling X; Zhang L; Qi C; Wei S; Zhang Y; Ma J
    EBioMedicine; 2024 Jan; 99():104920. PubMed ID: 38101299
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A systematic review and meta-analysis of prognostic indicators in patients with head and neck malignancy treated with immune checkpoint inhibitors.
    Kang D; Liu S; Yuan X; Liu S; Zhang Z; He Z; Yin X; Mao H
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):18215-18240. PubMed ID: 38078963
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic nutritional index and serum lactate dehydrogenase predict the prognosis of nasopharyngeal carcinoma patients who received intensity-modulated radiation therapy.
    Zhang C; Zhan Z; Fang Y; Ruan Y; Lin M; Dai Z; Zhang Y; Yang S; Xiao S; Chen B
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17795-17805. PubMed ID: 37934254
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Assessment of brush biopsy findings and salivary ldh levels in oral mucosal lesions of tobacco users.
    Davidson SP; Kumar S; Somasundaram E; Jaishankar S
    Indian J Dent Res; 2023; 34(2):191-195. PubMed ID: 37787211
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Epstein-Barr Virus Promotes Oral Squamous Cell Carcinoma Stemness through the Warburg Effect.
    Heawchaiyaphum C; Yoshiyama H; Iizasa H; Burassakarn A; Tumurgan Z; Ekalaksananan T; Pientong C
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762374
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Efficacy of induction chemotherapy in lymph node-positive stage III nasopharyngeal carcinoma and identification of beneficiaries based on clinical features: A propensity score matching analysis.
    Xu YC; Chen KH; Liang Y; Chen KQ; Liang ZG; Zeng FY; Li L; Qu S; Zhu XD
    Oral Oncol; 2023 Nov; 146():106554. PubMed ID: 37633201
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Nomogram Based on Liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy.
    Liang L; Li Y; Hong Y; Ji T; Chen H; Lin Z
    Curr Oncol; 2023 Jul; 30(8):7189-7202. PubMed ID: 37623002
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The efficacy and safety of sintilimab combined with chemotherapy as the first-line treatment for metastatic esophageal squamous cell carcinoma.
    Zhao Z; Yin MM; Zhao WF; Wang CJ
    Medicine (Baltimore); 2023 Aug; 102(33):e34794. PubMed ID: 37603519
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Pyrrolidinedione-thiazolidinone hybrid molecules with potent cytotoxic effect in squamous cell carcinoma SCC-15 cells.
    Finiuk N; Kaleniuk E; Holota S; Stoika R; Lesyk R; Szychowski KA
    Bioorg Med Chem; 2023 Sep; 92():117442. PubMed ID: 37579525
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.